# EPU2 – Validating HealthTech Innovation: Lessons from FMM × HCI

> Source: https://healthcareinnovation.tn/epu2-validating-healthtech-innovation-lessons-from-fmm-x-hci/
> Author: healthcareinnovation.com
> Published: 2024-02-10
> Updated: 2026-09-23

How do startups turn promising ideas into clinically credible products? The [Faculty of Medicine of Monastir (FMM)](https://www.fmm.rnu.tn/) and [HealthCare Innovation (HCI)](https://healthcareinnovation.tn/) convened a second postgraduate session to translate real‑world experience into a practical playbook for Tunisia’s HealthTech ecosystem. This article condenses the panel’s insights into actionable steps for conceptualization, validation, funding preparation, and collaboration frameworks—helping teams reduce risk and accelerate adoption.

## **Context & Panel**

 Held on 10 February 2024 in the ceremonial auditorium of the [Faculty of Medicine of Monastir (FMM)](https://www.fmm.rnu.tn/), the session gathered 100+ participants from regional university hospitals and HealthTech actors. Panelists included practitioners and founders sharing firsthand validation journeys. https://www.youtube.com/watch?v=6CIPxAVT8YA&t=1s

### **Why Validation Matters**

 HealthTech projects often stall between prototype and clinical use due to unclear validation pathways and fragmented collaboration. According to the [OECD](https://www.oecd.org/health/digital-health.htm), digital health ventures face scale‑up frictions, while the [WHO Global Strategy on Digital Health](https://www.who.int/publications/i/item/9789240068891) underscores governance, workforce capability, and interoperability as critical enablers.

#### **Insights → Actionable Steps**

 1) Learn from Experience‑Backed Validation Paths:

- Engage early with research labs and hospital departments to co‑design testing protocols and access instrumentation.
- Prototype with a clear risk‑reduction plan and generate objective test evidence before fundraising.

 2) Use Practical Collaboration Frameworks (Universities × Hospitals × Startups):

- Co‑author proposals between research labs and startups for pilot studies and validation.
- Leverage student final‑year projects to scope needs and build proof‑of‑concepts.
- Where implementing regulations lag, align under existing, recognized institutional frameworks to keep projects moving.

 3) Prepare for Funding with Evidence:

- Document validation results, user feedback, and safety data to improve investor negotiations.
- Present a credible team structure and milestone plan tied to validation gates.

 4) Build an Innovation Culture in Care Settings:

- Create clinician–startup working groups (e.g., junior HU assistants with founders).
- Provide continuous training in entrepreneurship, regulatory basics, and data practices.
- Enable the next generation to lead high‑value projects with structured mentorship.

 5) Bridge Equipment and Speed Gaps:

- Co‑design affordable research tools and validation rigs locally to reduce dependency and costs.
- Use stepwise pilots to de‑risk adoption while building institutional know‑how.

#### **HCI Resources**

 [Accelerating Innovation in HealthTech](https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/) [Startup Programs](https://healthcareinnovation.tn/service/startups/) [Pharma & Medical Device Regulatory Services](https://healthcareinnovation.tn/service/pharma-medical-device/) [Experts Network](https://healthcareinnovation.tn/experts/) [Community Overview](https://healthcareinnovation.tn/community/)

#### **External Citations**

 [OECD](https://www.oecd.org/health/digital-health.htm) — Digital Health Overview: WHO —[Global Strategy on Digital Health](https://www.who.int/publications/i/item/9789240068891) (2020–2025)

#### **FAQ**

 Q: How can a startup validate a prototype in Tunisia? A: Co‑design tests with hospital departments and research labs, run short pilots, and document outcomes to meet regulatory and investor expectations. Q: Which collaboration models work best? A: Joint lab–startup proposals, student project pipelines, and recognized institutional frameworks that formalize roles and responsibilities. Q: What should founders prepare before meeting investors? A: Evidence of validation, a stepwise plan with clear milestones, and a capable team aligned to clinical needs. Q: Where can I find support? A: Explore [HCI’s Startup Programs](https://healthcareinnovation.tn/service/startups/), the [HCI Experts Network](https://healthcareinnovation.tn/experts/), and [HCI Regulatory Services](https://healthcareinnovation.tn/service/pharma-medical-device/).

## Frequently asked questions

### Where can I find support?

Explore HCI’s Startup Programs, the HCI Experts Network, and HCI Regulatory Services.

### What should founders prepare before meeting investors?

Evidence of validation, a stepwise plan with clear milestones, and a capable team aligned to clinical needs.

### Which collaboration models work best?

Joint lab–startup proposals, student project pipelines, and recognized institutional frameworks that formalize roles and responsibilities.

### How can a startup validate a prototype in Tunisia?

Co‑design tests with hospital departments and research labs, run short pilots, and document outcomes to meet regulatory and investor expectations.